NYMC Faculty Publications

Plain Language Summary of Publication: A Comparison of Once-Monthly and Once-Every-2-Months Injectable Formulations of Aripiprazole in People With Schizophrenia

Author Type(s)

Faculty

DOI

10.1177/20451253241286319

Journal Title

Therapeutic Advances in Psychopharmacology

Document Type

Article

Publication Date

1-1-2024

Department

Psychiatry and Behavioral Sciences

Keywords

Antipsychotic, Aripiprazole, Long-acting injectable, Schizophrenia

Disciplines

Medicine and Health Sciences

Abstract

The purpose of this summary is to explain key findings from a study that included people with schizophrenia, as described in two separate articles (see the ‘Further Information’ section for more details). The study compared a new formulation of aripiprazole, given as an injection once every 2 months, with a once‑monthly injection of aripiprazole.

Share

COinS